These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9491507

  • 21. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.
    Loosmore SM, Zealey GR, Boux HA, Cockle SA, Radika K, Fahim RE, Zobrist GJ, Yacoob RK, Chong PC, Yao FL.
    Infect Immun; 1990 Nov; 58(11):3653-62. PubMed ID: 2228237
    [Abstract] [Full Text] [Related]

  • 22. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
    Chong P, Zobrist G, Sia C, Loosmore S, Klein M.
    Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
    [Abstract] [Full Text] [Related]

  • 23. Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon.
    Coynault C, Robbe-Saule V, Norel F.
    Mol Microbiol; 1996 Oct; 22(1):149-60. PubMed ID: 8899717
    [Abstract] [Full Text] [Related]

  • 24. Vectors to achieve selective expression of vaccine antigens within eukaryotic cells using Salmonella spp. as carrier strains.
    Basso H, Rohde M, Guzmán CA.
    FEMS Microbiol Lett; 2000 Jan 15; 182(2):219-23. PubMed ID: 10620669
    [Abstract] [Full Text] [Related]

  • 25. Pertussis toxin gene: nucleotide sequence and genetic organization.
    Locht C, Keith JM.
    Science; 1986 Jun 06; 232(4755):1258-64. PubMed ID: 3704651
    [Abstract] [Full Text] [Related]

  • 26. Mutants of pertussis toxin suitable for vaccine development.
    Pizza M, Covacci A, Bartoloni A, Perugini M, Nencioni L, De Magistris MT, Villa L, Nucci D, Manetti R, Bugnoli M.
    Science; 1989 Oct 27; 246(4929):497-500. PubMed ID: 2683073
    [Abstract] [Full Text] [Related]

  • 27. Construction and characterization of genetically inactivated pertussis toxin.
    Brown DR, Keith JM, Sato H, Sato Y.
    Dev Biol Stand; 1991 Oct 27; 73():63-73. PubMed ID: 1778335
    [Abstract] [Full Text] [Related]

  • 28. The potential Salmonella aroA- vaccine strain is safe and effective in young BALB/c mice.
    Burns-Guydish SM, Zhao H, Stevenson DK, Contag CH.
    Neonatology; 2007 Oct 27; 91(2):114-20. PubMed ID: 17344661
    [Abstract] [Full Text] [Related]

  • 29. Production and secretion of pertussis toxin subunits in Bacillus subtilis.
    Saris P, Taira S, Airaksinen U, Palva A, Sarvas M, Palva I, Runeberg-Nyman K.
    FEMS Microbiol Lett; 1990 Mar 01; 56(1-2):143-8. PubMed ID: 2110091
    [Abstract] [Full Text] [Related]

  • 30. Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter.
    Suarez A, Staendner LH, Rohde M, Piatti G, Timmis KN, Guzmán CA.
    Appl Environ Microbiol; 1997 Jan 01; 63(1):122-7. PubMed ID: 8979346
    [Abstract] [Full Text] [Related]

  • 31. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.
    Darji A, zur Lage S, Garbe AI, Chakraborty T, Weiss S.
    FEMS Immunol Med Microbiol; 2000 Apr 01; 27(4):341-9. PubMed ID: 10727890
    [Abstract] [Full Text] [Related]

  • 32. Construction and characterization of Bordetella pertussis toxin mutants.
    Black WJ, Falkow S.
    Infect Immun; 1987 Oct 01; 55(10):2465-70. PubMed ID: 2888733
    [Abstract] [Full Text] [Related]

  • 33. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP, Halperin SA, Morris A, MacMillan A, Lee SF.
    Can J Microbiol; 2006 May 01; 52(5):436-44. PubMed ID: 16699568
    [Abstract] [Full Text] [Related]

  • 34. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H, Sato Y.
    FEMS Microbiol Lett; 1994 Jan 01; 115(1):63-9. PubMed ID: 7510256
    [Abstract] [Full Text] [Related]

  • 35. Promoter of the pertussis toxin operon and production of pertussis toxin.
    Nicosia A, Rappuoli R.
    J Bacteriol; 1987 Jun 01; 169(6):2843-6. PubMed ID: 2438270
    [Abstract] [Full Text] [Related]

  • 36. Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium.
    Allen JS, Dougan G, Strugnell RA.
    FEMS Immunol Med Microbiol; 2000 Apr 01; 27(4):275-81. PubMed ID: 10727882
    [Abstract] [Full Text] [Related]

  • 37. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y, Hajishengallis G, Michalek SM.
    Infect Immun; 2001 Apr 01; 69(4):2154-61. PubMed ID: 11254570
    [Abstract] [Full Text] [Related]

  • 38. Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains.
    O'Callaghan D, Maskell D, Tite J, Dougan G.
    Immunology; 1990 Feb 01; 69(2):184-9. PubMed ID: 2106482
    [Abstract] [Full Text] [Related]

  • 39. Expression and immunological properties of the five subunits of pertussis toxin.
    Nicosia A, Bartoloni A, Perugini M, Rappuoli R.
    Infect Immun; 1987 Apr 01; 55(4):963-7. PubMed ID: 3549567
    [Abstract] [Full Text] [Related]

  • 40. Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.
    Zealey GR, Loosmore SM, Yacoob RK, Cockle SA, Herbert AB, Miller LD, Mackay NJ, Klein MH.
    Appl Environ Microbiol; 1992 Jan 01; 58(1):208-14. PubMed ID: 1539974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.